The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Mycoplasma Gallisepticum Vaccine (TS-11)This page contains information on Mycoplasma Gallisepticum Vaccine (TS-11) for veterinary use.
The information provided typically includes the following:
- Mycoplasma Gallisepticum Vaccine (TS-11) Indications
- Warnings and cautions for Mycoplasma Gallisepticum Vaccine (TS-11)
- Direction and dosage information for Mycoplasma Gallisepticum Vaccine (TS-11)
Mycoplasma Gallisepticum Vaccine (TS-11)This treatment applies to the following species:
Mycoplasma gallisepticum, Live Culture, MG TS-11
U.S. Vet. Lic. No.: 279
Active Ingredient(s): The vaccine contains the TS-11 strain of Mycoplasma gallisepticum (MG), live culture.
Contains amoxicillin as a preservative.
Notice: The vaccine has met the requirements of the USDA in regards to safety, purity, potency, and the capability to protect susceptible chickens. The vaccine has been tested by the master seed immunogenicity test for efficacy.
Mycoplasma Gallisepticum Vaccine (TS-11) Indications
The vaccine is for the vaccination of healthy chickens nine weeks of age or older as an aid in the prevention of clinical signs of MG infection.
The vaccine is recommended for use in healthy chickens only. It is essential that the chickens be maintained under good environmental conditions and that exposure to disease viruses be reduced as much as possible in the field. Do not use in breeder chickens where negative MG serology is desired or required.
Dosage and AdministrationRead the full directions carefully.
1. Bottles should be rapidly thawed in warm water (Caution: No warmer than 30°C or 86°F). Shake well before removing the cap.
2. Remove the cap and stopper and insert the dropper tip.
3. Hold each bird with its head tilted to one side.
4. Place one (1) drop on the eye allowing the drop to spread over the eye before releasing the bird.
5. Use the entire contents when first thawed.
Precaution(s): MYCOPLASMA GALLISEPTICUM VACCINE is a frozen vaccine; store at -40°F (-40°C) or lower until ready for use.
Caution(s): Do not vaccinate MG positive or diseased birds.
Vaccinate all of the birds on the premises at one time.
Administer a minimum of one dose for each bird.
Vaccination should be carried out at least three weeks before expected exposure to the field type MG.
Avoid stress conditions during and following vaccination.
Do not place chickens in contaminated facilities.
For veterinary use only.
Do not medicate chickens with antibacterial drugs 14 days before or seven days after vaccination.
The capability of the vaccine to produce satisfactory results depends upon many factors including, but not limited to, conditions of storage and handling by the user, administration of the vaccine, health and responsiveness of individual animals and the degree of field exposure. Directions for use should be followed carefully. The use of the vaccine is subject to applicable local and federal laws and regulations.
Use the entire contents when first opened. Burn the container and all unused contents.
Use only in localities where permitted.
Do not use in breeders.
Warning(s): Do not vaccinate within 21 days before slaughter.
Presentation: 10 x 1,000 doses frozen.
NAC No.: 11050281
Merial is now part of Boehringer Ingelheim
P.O. BOX 2497, GAINESVILLE, GA, 30503
|Every effort has been made to ensure the accuracy of the Mycoplasma Gallisepticum Vaccine (TS-11) information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-05-30